ZEISS Redefines Disease Management and Treatment Within the ZEISS Retina Workflow
ZEISS Redefines Disease Management and Treatment Within the ZEISS Retina Workflow
Showcasing at EURETINA 2024: ZEISS will highlight new surgical innovations and artificial intelligence (AI) tools for retinal patient care, helping doctors diagnose and treat patients efficiently and effectively:
在EURETINA 2024上展出：蔡司將重點介紹用於視網膜患者護理的新外科創新和人工智能（AI）工具，幫助醫生高效地診斷和治療患者：
- THE FUTURE OF VITREORETINAL SURGERY: Demonstrating the ZEISS ARTEVO 850 3D digital visualization system, Single-use Lenses for ZEISS RESIGHT, and the EVA NEXUS surgical system from DORC.
- AI ADVANCEMENTS FOR RETINA PATIENTS: CIRRUS PathFinder introduces a paradigm shift in the ability to streamline OCT data review, including large amounts of OCT scans flagging macular B-scans that may require closer review.
- SIMPLIFIED SURGICAL VIDEO MANAGEMENT: Showing a digital application for experiencing 3D videos and more on the Apple Vision Pro, offering surgery video review, analysis, and sharing post-surgery.
- 玻璃體視網膜手術的未來：演示蔡司ARTEVO 850 三維數字可視化系統、蔡司 reSIGHT 一次性鏡頭和 DORC 的 EVA NEXUS 手術系統。
- 視網膜患者的人工智能進步：CIRRUS PathFinder在簡化oCT數據審查的能力方面引入了模式轉變，包括大量的OcT掃描標記黃斑b掃描，可能需要仔細審查。
- 簡化的手術視頻管理：展示用於在 Apple Vision Pro 上體驗 3D 視頻及更多內容的數字應用程序，提供手術視頻回顧、分析和術後共享。
JENA, Germany, Sept. 12, 2024 /PRNewswire/ -- ZEISS Medical Technology will showcase digital innovations and its latest 3D visualization technology as part of the ZEISS Retina Workflow at the European Society of Retina Specialists (EURETINA) conference. The new solutions within the ZEISS Medical Ecosystem help improve the diagnosis and treatment of retinal patients using the latest integrated, digital technologies.
德國耶拿，2024年9月12日 /PRNewswire/ — 作爲蔡司視網膜工作流程的一部分，蔡司醫療科技將在歐洲視網膜專家協會（EURETINA）會議上展示數字創新及其最新的三維可視化技術。蔡司醫療生態系統中的新解決方案使用最新的集成數字技術幫助改善視網膜患者的診斷和治療。
譯文內容由第三人軟體翻譯。